Qyuns Therapeutics Shareholders Approve Transaction Caps and Director AppointmentTip Ranks·Nov 13, 2026 at 12:09 PM02509-0.07%
QYUNS climbs 7% on $30M upfront from Caldera antibody dealMarket Movers·Nov 6, 2026 at 01:31 AM02509-0.07%
Qyuns Therapeutics Proposes Ji Juan as Non-Executive DirectorPUBT·Oct 27, 2026 at 09:03 AM02509-0.07%
From CAR-T Breakthroughs to Power Market Overhaul: Hong Kong's Niche Champions Gain MomentumGlobal Report·Oct 20, 2026 at 10:16 AM01548+4.12%02509-0.07%
Leadership Shakeup Signals Strategic Shifts Across 10 Hong Kong Small-CapsGlobal Report·Oct 13, 2026 at 10:14 AM00550-0.87%02706+0.28%
Qyuns Therapeutics’ Oturkibart Shows Strong Phase III PN Data at EADV 2026Tip Ranks·Oct 2, 2026 at 12:07 AM02509-0.07%
Qyuns Therapeutics Updates Board Composition and Governance StructureTip Ranks·Sep 22, 2026 at 02:08 PM02509-0.07%
Power On: ETF Inflows and Strategic Turnarounds Define Hong Kong Market ShiftsGlobal Report·Sep 22, 2026 at 11:33 AM01757+3.14%029280.00%